Pathology

1. Tahir NA, Al-Allawi NA. Health-related quality of life in adults with sickle cell disease in Duhok-Iraq. Iraqi J Hematol 2022;11:70-5.
2. Atroshi SD, Al-Allawi NAS, Eissa AA. Updated Molecular Spectrum of β-Thalassemia Mutations in Duhok Province, Northern Iraq: Ethnic Variation and the Impact of Immigration. Hemoglobin. 2021 Jul;45(4):239-244.
3. Atroshi SD, Al-Allawi N, Chui DHK, Najmabadi H, Khailany RA. A Novel β0-Thalassemia Mutation, HBB: c.356_357delTT [Codon 118 (-TT)] in an Iraqi Kurd. Hemoglobin. 2021 May;45(3):212-214.
4. Mohammed DJ, Jalal SD, Yassin AK, Mohammed AI, Al-Allawi NA. The Outcome of Acute Lymphoblastic Leukemia in 109 Adult Iraqi Patients. Indian J Hematol Blood Transfus. 2021 Apr;37(2):264-270.
5. Hasan KH, Sofijanova A, Hassan L, Al-Allawi N. Deferasirox Effect on Serum Ferritin in Iraq Patients with Hemoglobinopathies: A Single Center Experience. Open Access Macedonian Journal of Medical Sciences. 2021 Feb 12;9(B):144-8.
6. Mohammad AM, Dawad MM, Kashmoola MA, Al-Allawi N. Doppler-defined pulmonary hypertension in β-thalassemia major in Kurdistan, Iraq. PLoS One. 2020 Dec 10;15(12):e0243648.
7. Mohammad AM, Othman GO, Saeed CH, Al Allawi S, Gedeon GS, Qadir SM, Al-Allawi N. Genetic polymorphisms in early-onset myocardial infarction in a sample of Iraqi patients: a pilot study. BMC Res Notes. 2020 Nov 24;13(1):541.
8. Al-Allawi N, Al Allawi S, Jalal SD. Genetic epidemiology of hemoglobinopathies among Iraqi Kurds. J Community Genet. 2021 Jan;12(1):5-14.
9. Sadullah RK, Atroshi SD, Al-Allawi NA. Complications and Challenges in the Management of Iraqi Patients with β-Thalassemia Major: A Single-center Experience. Oman Med J. 2020 Jul 27;35(4):e152.
10. Rajab RN, Hiwaizi F, Yassin AK,, … Al-Allawi NAS,…., Mohammed NS. Effectiveness of antiplatelet thromboprophylaxis in myeloma patients using immunomodulators in Kurdistan region-Iraq. Ann Coll Med Mosel 2020; 42 (1):35-41.
11. Badi AI, Al-Allawi NA, Yassin AK, Safar BM, Abdulla BK, Shamoon RP, Amin TA, Mohamed ZA, Mohammed AI, Hussein DJ, Hasan KM. Health-related quality of life in multiple myeloma in Kurdistan Iraq. Iraqi Journal of Hematology. 2020 Jul 1;9(2):101.
12. TAHIR DA, AL-ALLAWI NA, KHADUM VM, MOHAMMED AJ. Health-related quality of life in sickle cell disease patients in Akre, Iraqi Kurdistan. Duhok Medical Journal. 2019 Dec 1;13(2):31-43.
13. Albarawi DJ, Balatay AA, Al-Allawi N. HBG2 -158 (C>T) polymorphism and its contribution to fetal hemoglobin variability in Iraqi Kurds with beta-thalassemia minor. J Lab Physicians. 2018 Oct-Dec;10(4):370-373.
14. Al-Allawi N, Qadir SMA, Puehringer H, Chui DHK, Farrell JJ, Oberkanins C. The association of HBG2, BCL11A, and HMIP polymorphisms with fetal hemoglobin and clinical phenotype in Iraqi Kurds with sickle cell disease. Int J Lab Hematol. 2019 Feb;41(1):87-93.
15. SALIH RY, YAQO RT, AL ALLAWI SA, AL-ALLAWI NA. Hodgkin lymphoma and its association with Epstein-Barr virus in Kurdistan, Northern Iraq. Duhok Medical Journal. 2019 Dec 1;13(2):74-83.
16. Mikael NA, Al-Allawi NA. Factors affecting quality of life in children and adolescents with thalassemia in Iraqi Kurdistan. Saudi Med J. 2018 Aug;39(8):799-807.
17. Mohammad AM, Al-Allawi NAS. CYP2C19 Genotype is an Independent Predictor of Adverse Cardiovascular Outcome in Iraqi Patients on Clopidogrel After Percutaneous Coronary Intervention. J Cardiovasc Pharmacol. 2018 Jun;71(6):347-351.
18. Jalal SD, Al-Allawi NA, Eldosky AA. Immunophenotypic aberrancies in acute lymphoblastic leukemia from 282 Iraqi patients. International J Lab. Hematology 2017; Dec 39(6): 625-632. (IF 2.05)
19. Salih DJ, Bakir N, Eissa AA, Al-Allawi NA. Clinical and cytogenetic profile in patients with Down syndrome in Duhok province, Iraq. Medical Journal of Babylon. 2017;14(2):389-401.
20. Hasan KM, Al-Allawi NA, Badi AI. Multilineage dysplasia in Iraqi Kurds with acute myeloid leukemia: A retrospective study on 105 patients. Duhok Medical Journal. 2017;11(2):1-0.
21. Albarawi D, Alalsaidissa JN, Al-Allawi NA. Absence of sp1 transcription factor variant in 102 iraqi patients with beta thalassemia intermedia. Duhok Medical Journal. 2017;11(1):1-7.
22. Al-Allawi NA. Epidemiology, care and prevention of Hemoglobinopathies. Online Course for the Geneva foundation for Medical Education and Research (2017). Available from https://www.gfmer.ch>pdf.
23. Jiang Z, Luo HY, Farrell JJ, Zhang Z, Schulz VP, Albarawi D, Steinberg MH, Al-Allawi NA, Gallagher PG, Forget BG, Chui DHA variant Sp1 (R218Q) transcription factor might enhance Hb expression in b0-thalassaemia homozygotes. Br J Haematol. 2017 Feb 27. doi: 10.1111/bjh.14445. [Epub ahead of print] (IF 5.3)
24. Eissa AA, Makous RD, Yahya NB, Al-Allawi NAS. Hemoglobin F Modulation in Sickle Cell Disease: Experience of a single center in Iraqi Kurdistan. J. Applied Hematology 2016 Sept. ; 7: 85-89.
25. Al-Allawi N, Mohammad AM, Jalal S. Doppler-Defined Pulmonary Hypertension in Sickle cell Anemia in Kurdistan, Iraq. Plos One 2016 Sept: 11(9): e0162036.doi:10.1371/journal.pone.0162036 (5 yr IF average 3.5)
26. Scott EM, Halees A, Itan Y, Spencer EG, He Y, Azab MA, Gabriel SB, Belkadi A, Boisson B, Abel L, Clark AG; Greater Middle East Variome Consortium*, Alkuraya FS, Casanova JL, Gleeson JG. Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery. Nat Genet. 2016 Sep; issue 9; Vol 48:1071-6. (*Dr N Al-Allawi)
27. Zhihua Jiang Z, Luo H, Huang S,…., Al-Allawi NAS,….Chui DHK . The genetic basis of asymptomatic codon 8 frame-shift (HBB:c25_26delAA) β0-thalassaemia homozygotes. Brit. J Haematol 2016 ; 172(6):958-65.
28. Al-Allawi NA, Badi AI, Goran MA, Nerweyi FF, Ballo HM, Al-Mzury NT.The Contributions of Thrombophilic Mutations to Genetic Susceptibility to Deep Venous Thrombosis in Iraqi Patients. Genet Test Mol Biomarkers. 2015; 19(9):500-4.
29. Al-Mousawi MMN, Al-Allawi NAS, Alnaqshabandi R. Predictors of Red Cell Alloimmunization in Kurdish Multi Transfused Patients with Hemoglobinopathies in Iraq. Hemoglobin 2015 39(6):423-6.
30. Shamoon RP, Al-Allawi NA, Cappellini MD, Pierro E, Brancaleoni V, Granata F. Molecular Basis of β-thalassemia intermedia in Erbil Province of Iraqi Kurdistan. Hemoglobin 2015 ; issue 3; vol 39; 178-83
31. Eissa AA, Kashmoola MA, Atroshi SD, Al-Allawi NA.Molecular characterization of β-thalassemia in Nineveh province illustrates the relative heterogeneity of Mutation Distributions in Northern Iraq. Indian J Hematology and Blood Transfusion 2015 Jun; issue 2; vol 31; 213-7.
32. Al-Allawi NA, Puehringwe H, Raheem RA, Oberkanins C. Genetic Modifiers in β-thalassemia intermedia: A study on 102 Iraqi Arab patients. Genet Test Mol Biomarkers 2015 May; issue 5 : volume 19: 242-7
33. Kashmoola MA, Eissa AA, Al-Takay DT, Al-Allawi NA. Molecular characterization of G6PD deficient variants in Nineveh Province, Northwestern Iraq. Indian J Hematology and Blood Transfsuion 2015 March; issue 1; vol 31: pp 133-6.
34. Al-Allawi NA, Al-Doski AA, Markous RS, Mohamad AKA, Eissa AA, Badi AI, Asmaro RR, Hamamy H. Premarital Screening for hemoglobinopathies: experience of a single center in Kurdistan, Iraq. Public Health Genomics 2015 Feb; issue 2; volume 18: 97-103.
35. Hamamy H, Makrythanasis P, Al-Allawi N, Muhsin AA, Antonarakis SE (2014) Recessive thrombocytopenia likely due to a homozygous pathogenic variant in the FYB gene: case report. BMC Medical genetics . 2014 Dec 17;15:135. doi: 10.1186/s12881-014-0135-0.
36. Al-Allawi NA, Shamdeen MY, Mohammed QO, Ahmed AS . Activated protein C resistance and antiphospholipid antibodies in recurrent fetal loss: experience of a single referral center in northern iraq. Indian J Hematol Blood Transfus. 2014 Dec;30(4):364-9
37. Makrythanasis P, Nelis M, Santoni FA, Guipponi M, Vannier A, Béna F, Gimelli S, Stathaki E, Temtamy S, Mégarbané A, Masri A, Aglan MS, Zaki MS, Bottani A, Fokstuen S, Gwanmesia L, Aliferis K, Bustamante Eduardo M, Stamoulis G, Psoni S, Kitsiou-Tzeli S, Fryssira H, Kanavakis E, Al-Allawi N, Sefiani A, Al Hait S, Elalaoui SC, Jalkh N, Al-Gazali L, Al-Jasmi F, Bouhamed HC, Abdalla E, Cooper DN, Hamamy H, Antonarakis SE. Diagnostic exome sequencing to elucidate the genetic basis of likely recessive disorders in consanguineous families. Hum Mutat. 2014 Oct;35(10):1203-10
38. Ali MD, Badi AI, Al-Zebari SS, Al-Allawi NA. Response to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia : Experience from a West Asian Developing Country. Int. J. Hematology 2014 Sept; issue 3; vol 100: 274-9
39. Al-Allawi NA, Jalal SD, Mohammad AM, et al. β-thalassemia Intermedia in Northern Iraq: A single center experience. BioMed Research International. 2014 Feb ; 2014:262853. doi: 10.1155/2014/262853..
40. Novarino G, Fenstermaker AG, Zaki MS, ……, Al-Allawi N,……Glesson J (2014). Exome Sequencing Links Corticospinal motor neuron disease to common neurodegenerative disorders. Science 343, 506-511.
41. Othman AA, Eissa AA, Markous RD, Ahmed BD, Al-Allawi NA (2014). Hepatitis C Virus genotypes in Multiply transfused Haemoglobinopathy patients in Northern Iraq. Asian J Transfusion Science. 8(1): 32-34.
42. Al-Allawi NA, Jalal SD, Ahmed NH, et al (2013). The first five years of a preventive programme for haemoglobinopthies in Northern Iraq. J Med Screen, 20(4): 171-6.
43. Al-Allawi N, Al-Musawi B, Badi A, Jalal S (2013). The Spectrum of β-thalassemia mutations in Baghdad-Central Iraq. Hemoglobin. 37 (5): 444-453.
44. Hamamy H, Al-Allawi N (2013). The Epidemiology of Haemoglobinopathies in Arab Countries. J Community Genetics. 4(2):147-167.
45. Al-Allawi N, Jalal S, Rasheed N, et al (2013). The spectrum of Alpha thalassemia mutations in the Kurdish population of Northeastern Iraq. Hemoglobin. 37 (1): 56-64.
46. Al-Allawi N, Nerwey F, Jassim D, et al.(2012) Xmn I polymorphism in thalassemia patients in Duhok. DMJ 2012, 6(1); 1-7.
47. Al-Allawi N, Ismaeel AT, Ahmed N, Merza NS (2012). Frequency and Spectrum of K-ras mutations in Iraqi patients with Colorectal Cancer. Indian J cancer 49 (1); 163-168.
48. Al-Sammarrai A, Hilmi F, Al-Allawi N., Murad AF (2012). Antiphospholipid antibodies in Iraqi women with recurrent midtrimester abortion. J Lab Physicians ; 4(2): 76-80.
49. Al-Allawi N, Jalal S, Nerwey F, et al (2012) Sickle Cell Disease in the Kurdish population of Northern Iraq. Hemoglobin 36(4):333-42.
50. Al-Musawi BMS, Al-Allawi N, Abdul-Majeed BA, Eissa AA, Jubrael JMS, Hamamy H (2012). Molecular Characterization of glucose-6-phosphate dehydrogenase deficient variants in Baghdad city-Iraq. BMC blood disorders 2012, 12:4
51. .Eissa A, Muhammed FA, Mohammed AI, Al-Allawi NAS, et al (2011). Prevalence and molecular characterization of G6PD variants in Sulymania province –Iraq. Duhok Medical Journal: 5(2):69-75.
52. Yaqo RH, Hughson M, Sulyvani F, Al-Allawi NA (2011). Malignant Lymphoma in Northern Iraq: A retrospective analysis of 270 cases according to WHO classification. Indian J cancer 48; 446-451.
53. Abdulrahman K, Al-Allawi N, Muhsen AA (2011) Pattern of Acute Lymphoblastic Leukemia among Kurdish Children in Duhok city, Northern Iraq. Qatar Medical Journal 20(2): 17-20
54. Al-Allawi N, Jubrael JMS, Hilmi FA (2011). Factor V Leiden mutation in Iraqi patients with deep venous thrombosis. J Fac Med (Bag) ; 53(3): 293-295
55. Jalal S, Al-Allawi N, Bayat N, et al (2010). Beta thalassemia mutations in the Kurdish population of Northeastern Iraq. Hemoglobin 34(5): 469-476
56. Al-Allawi N and El-Dosky A (2010). Frequency of haemoglobinopathies at a premarital health screening center in Dohuk, Iraq : implications for a regional preventive programme. East Mediterranean Health Journal (WHO): 16(4); 381-385.
57. Al-Allawi N, et al (2010). Homozygosity to the Mediterranean alpha thalassemia deletion (Hb Barts Hydrops fetalis): first case report from Iraq. Annals of Saudi Medicine, 30(2); 153-155.
58. Al-Allawi N, Hassan KMA, Sheikha A, et al (2010). Beta thalassemia mutations among transfusion dependent thalassemia major patients in Northern Iraq. Molecular Biology International 2010, ID 479282.
59. Al-Allawi N, Eissa AA, Jubrael J, et al (2010) Prevalence and Molecular characterization of G6PD deficient variants in the Kurdish population of Northern Iraq. BMC blood disorders 2010; 10:6.
60. Neirway F, Al-Allawi N, Jubrael J (2010). The application of the amplification refractory Mutation System for the Characterization of beta thalassemia mutation in Duhok. Duhok Medical Journal: 4(2) : 8-20.
61. Al-Allawi N, Avo A, Jubrael J (2009). Methylenetetrahydrofolate reductase C677T polymorphism among Iraqi patients with Ischemic stroke. Neurol India 57; 631-5.
62. Al-Allawi N, et al. (2009) Molecular characterization of alpha thalassemia in Dohuk region of Iraq. Hemoglobin 33; 37-44.
63. Al-Allawi N, Jubrael J., Baban N, Gedeon G (2009) Thrombophilic mutations in Dohuk region of Iraq. Duhok Medical Journal; 3: 25-32.
64. Al-Allawi N. (2008). The preventive program for Hemoglobinopathies in Dohuk, an option or a necessity. Duhok Medical Journal : 2; 1-4. (Editorial).
65. Jalal S, Al-Allawi N, et al (2008). Prevalence of Hemoglobinopathies in Sulymani - Iraq. Duhok Medical Journal, 2, 71-9
66. Al-Allawi N, Jubrael J., Hughson M.(2006) Molecular Characterization of b thalassemias in Dohuk Region of Iraq. Hemoglobin ; 30 ; 479-86.
67. Al-Allawi N, Hilmi F, Jubrael J, Al-Ameri A. (2005). Factor V Leiden and venous thrombosis : First case reports from Iraq. J Fac. Med.(Bag) 47: 50-53.
68. Al-Allawi N. (2004). Anticardiolipin antibodies in young Iraqi adults with Deep venous thrombosis. Iraqi Postgraduate Medical Journal ; 3: 124-128.
69. AL-Allawi N, Jubrael J, Hilmi F. Factor V Leiden in Blood Donors in Baghdad (Iraq). Clin Chem 2004; 50: 677-678.
70. Al-Allawi N, et al (2002). Antiphospholipid antibodies in Systemic Lupus erythematosus: Clinical and Laboratory correlations. J. Fac. Med. (Baghdad), 44; 18-24.
71. Hilmi F, Al-Allawi N., Rassam M et al (2002). Red cell G6PD phenotypes in Iraq. Eastern Mediterranean Health Journal (WHO), 8: 42-48.
72. Yahya H, Al-Allawi N, Matter Y (2000). Acute lymphoblastic Leukaemia in 70 Iraqi adults: clinical and Haematological findings and outcome. Indian J. Cancer, 37; 85-90.
73. Jawad A, Al-Allawi N (1999). Surreptitious ingestion of oral anticoagulants : Review of four cases. J. Fac. Med. (Baghdad), 41; 351-354.
74. Abada S., Al-Allawi N, Jafar AK (1998). Multiple Myeloma : A Clinico-pathological study on 80 unselected Iraqi patients. Journal of Saddam University, 1 (4):33-40.
75. Khalaf AR, Al-Fahad S, Al-Allawi N (1997). Antiphospholipid Syndrome ; J. Fac. Med. (Baghdad), 39; 204-212
76. Yahya HI, Khalel K, Al-Allawi N, Hilmi F (1996). Thalassaemia genes in Baghdad City-Iraq. Eastern Mediterranean Health Journal (WHO), 2; 315-319.
77. Jawad A, Al-Allawi N (1996). Bleomycin, doxorubicin and prednisolone combination for induction of high risk Acute Lymphoblastic Leukaemia. J. Fac. Medicine (Baghdad), 38; 126-131.
78. Jawad A, Al-Allawi N (1996). Acute Lymphoblastic Leukaemia with lymphomatous features : Poor response to conventional induction therapy. . J. Fac. Medicine (Baghdad), 38; 8-12.
79. Al-Allawi N (1995). Chronic Myeloid Leukaemia in blastic crisis : the experience of the Medical city. J. Fac. Med. (Baghdad); 37 : 401-408.
80. Al-Haddad S, Hilmi F, Al-Allawi N (1995). Neuroblastoma in Iraq : The experience of a major teaching hospital in Baghdad. J. Fac. Med. (Baghdad), 1995 ; 37 : 432-440.
81. Hilmi F, Al-Allawi N, Al-Attar A (1993). Haematological changes in Kala-azar: a study on 82 Iraqi patients. J. Community Medicine, 6; 58-90.
82. Yahya HI, Al-Allawi N (1993). Acute haemolytic episodes and fava bean consumption in G6PD deficient Iraqis. Indian J. Med. Research, 98; 290-292.
83. Jawdat I, Al-Ousi J, Al-Allawi N, Strack J (1993). The interaction between sickle cell gene and G6PD deficiency in Basrah. J. Fac. Med. (Baghdad), 35; 603-609.
84. Al-Allawi N, et al (1992). Chronic Lymphocytic Leukaemia: Clinical staging and bone marrow biopsy patterns in 68 Iraqi patients. J. Fac. Med. (Baghdad) 34; 445-451
85. Al-Allawi N, et al (1991). Acute Myeloid Leukaemia: Morphological subtyping and haematological findings in 214 Iraqi adults. J. Fac. Med. (Baghdad) 33; 59-71.
86. Baban NK, Al-Allawi N, Hilmi F, Al-Sabah SL, Al-Nakshabandi A (1989). The distribution of the major blood groups in the city of Baghdad: a study on 30771 cases. Proceedings of third Al-Azhar International Medical conference; pp232-238.
87. Al-Allawi N, et al (1988). Restriction endonuclease mapping for the diagnosis of Alpha thalassaemia in Afrocarribeans. Proceedings of the British Society of Haematology Conference, Lancaster, UK. Published as an abstract in BJH 1988.
88. Al-Rawi ZT, Al-Khoja M, Al Allawi NAS (1986). Pathogenesis of vaginal discharge. J Fac. Med (Bagh) 28(4): 49-62.
89. Several other abstracts at the proceedings at American Society of Hematology ASH, European Conferences of Genetics, Emirates hematology conferences.. etc.

Inherited Red cell disorders, Thrombophilia, Leukemia and Lymphoma

2021-now: Teaching the Undergraduate Selective Course: Practical Hematopathology.

2004-now : Teaching duties to undergraduate and Postgraduate medical students of Medical Genetics and Haematology, College of Medicine, University of Duhok, Duhok, Iraq.

1988-2004: Teaching duties (Haematology-theory and Practical) to undergraduate and postgraduate Medical students at the College of Medicine, University of Baghdad, Baghdad, Iraq.

1996-now : Training and supervision of Iraqi Board trainees in Haematology.

2012-now: Training and supervision of Kurdistan Board trainees in Haematology.

Supervisions 1996-2023 included a total of 62 thesis or dissertations:

30 dissertations of Iraqi and Kurdistan board medical specialties (Hematopathology, Clinical Hematology and Histopathology)
11 thesis PhD (two for College of Medicine, University of Baghdad and two for College of Medicine, University of Dohuk, three for the college of Science, University of Duhok, four for the Hawler Medical university, college of Medicine)
21 thesis Masters (17 for University of Duhok, college of Medicine and Science; 3 for University of Baghdad and One for the Arabian University of Beirut Lebanon)

The latest ones
May 2023 : Moderator at the First Scientific conference of Kurdistan's Doctors' Syndicate at the university of Duhok, Kurdistan Iraq.

March 2023. Keynote speaker at the 3rd international conference on Medical and biological technologies at Duhok polytechnic University, Duhok, Iraq.

October 2022 The Second workshop for Bleeding and thrombotic disorders (4 working days) Organizer and Keynote speaker.

April 2022 First workshop on the diagnosis of malignant Lymphoma. Moderator.

October 2021 Virtual postgraduate Workshop on problem resolution in transfusion medicine. Keynote speaker and organizer.

May 2018 Participant at the 31st International symposium on Technical innovation in laboratory hematology. Brussels, Belgium.

Download